Found 1412 results
[ Author(Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
R. J. Bildfell, Rumbeiha, W. K., Schuler, K. L., Meteyer, C. U., Wolff, P. L., and Gillin, C. M., A review of episodes of zinc phosphide toxicosis in wild geese (Branta spp.) in Oregon (2004-2011)., Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc, vol. 25, no. 1, pp. 162-7, 2013.
F. M. Biel, Allen, F. A., and Häse, C. C., Autolysis in Vibrio tubiashii and Vibrio coralliilyticus., Canadian journal of microbiology, vol. 60, no. 2, pp. 57-63, 2014.
R. J. Bickers, Templer, A., Cebra, C. K., and Kaneps, A. J., Diagnosis and treatment of torsion of the spiral colon in an alpaca., Journal of the American Veterinary Medical Association, vol. 216, no. 3, pp. 380-2, 2000.
S. Bhattacharya, Li, S., Wheeler, H., Wang, R., Löhr, C. V., Leid, M., Ganguli-Indra, G., and Indra, A. K., Ablation of Ctip2/Bcl11b in Adult Epidermis Enhances TPA/UV-Induced Proliferation and Increases Susceptibility to DMBA/TPA-Induced Epidermal Carcinogenesis., J Invest Dermatol, vol. 137, no. 7, pp. 1594-1598, 2017.
L. E. Bermudez, Parker, A., and Petrofsky, M., Apoptosis of Mycobacterium avium-infected macrophages is mediated by both tumour necrosis factor (TNF) and Fas, and involves the activation of caspases., Clinical and experimental immunology, vol. 116, no. 1, pp. 94-9, 1999.
L. E. Bermudez and Young, L. S., Factors affecting invasion of HT-29 and HEp-2 epithelial cells by organisms of the Mycobacterium avium complex., Infection and immunity, vol. 62, no. 5, pp. 2021-6, 1994.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Chee, C. B., Aralar, P., Petrofsky, M., Parman, T., Green, C. E., Lewin, A. H., Ellis, W. Y., and Young, L. S., Identification of (+)-Erythro-Mefloquine as an Active Enantiomer with Greater Efficacy than Mefloquine against Mycobacterium avium Infection in Mice., Antimicrobial agents and chemotherapy, vol. 56, no. 8, pp. 4202-6, 2012.
L. E. Bermudez, Potential role of cytokines in disseminated mycobacterial infections., European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, vol. 13 Suppl 2, pp. S29-33, 1994.
L. E. Bermudez and Young, L. S., Tumor necrosis factor alpha stimulates mycobactericidal/mycobacteriostatic activity in human macrophages by a protein kinase C-independent pathway., Cellular immunology, vol. 144, no. 2, pp. 258-68, 1992.
L. E. Bermudez, Petrofsky, M., Sommer, S., and Barletta, R. G., Peyer's patch-deficient mice demonstrate that Mycobacterium avium subsp. paratuberculosis translocates across the mucosal barrier via both M cells and enterocytes but has inefficient dissemination., Infection and immunity, vol. 78, no. 8, pp. 3570-7, 2010.
L. E. Bermudez, [Bacteremias in immunosuppressed patients]., Revista paulista de medicina, vol. 104, no. 2, pp. 87-92, 1986.
L. E. Bermudez, Young, L. S., and Enkel, H., Interaction of Mycobacterium avium complex with human macrophages: roles of membrane receptors and serum proteins., Infection and immunity, vol. 59, no. 5, pp. 1697-702, 1991.
L. E. Bermudez and Kaplan, G., Recombinant cytokines for controlling mycobacterial infections., Trends in microbiology, vol. 3, no. 1, pp. 22-7, 1995.
L. E. Bermudez and Young, L. S., Recombinant granulocyte-macrophage colony-stimulating factor activates human macrophages to inhibit growth or kill Mycobacterium avium complex., Journal of leukocyte biology, vol. 48, no. 1, pp. 67-73, 1990.
L. E. Bermudez, Petrofsky, M., Kolonoski, P., and Young, L. S., Emergence of Mycobacterium avium populations resistant to macrolides during experimental chemotherapy., Antimicrobial agents and chemotherapy, vol. 42, no. 1, pp. 180-3, 1998.
L. E. Bermudez, Martinelli, J., Petrofsky, M., Kolonoski, P., and Young, L. S., Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model., The Journal of infectious diseases, vol. 169, no. 3, pp. 575-80, 1994.
L. E. Bermudez, Production of transforming growth factor-beta by Mycobacterium avium-infected human macrophages is associated with unresponsiveness to IFN-gamma., Journal of immunology (Baltimore, Md. : 1950), vol. 150, no. 5, pp. 1838-45, 1993.
L. E. Bermudez, Nash, K., Petrofsky, M., Young, L. S., and Inderlied, C. B., Clarithromycin-resistant mycobacterium avium is still susceptible to treatment with clarithromycin and is virulent in mice., Antimicrobial agents and chemotherapy, vol. 44, no. 10, pp. 2619-22, 2000.
L. E. Bermudez and Young, L. S., Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complex., Antimicrobial agents and chemotherapy, vol. 32, no. 8, pp. 1149-53, 1988.
L. E. Bermudez and Petrofsky, M., Regulation of the expression of Mycobacterium avium complex proteins differs according to the environment within host cells., Immunology and cell biology, vol. 75, no. 1, pp. 35-40, 1997.
L. E. Bermudez, Petrofsky, M., Kolonoski, P., and Young, L. S., An animal model of Mycobacterium avium complex disseminated infection after colonization of the intestinal tract., The Journal of infectious diseases, vol. 165, no. 1, pp. 75-9, 1992.
L. E. Bermudez, Wagner, D., and Sosnowska, D., Mechanisms of Mycobacterium avium pathogenesis., Archivum immunologiae et therapiae experimentalis, vol. 48, no. 6, pp. 521-7, 2000.
L. E. Bermudez, Kolonoski, P., and Young, L. S., Roxithromycin alone and in combination with either ethambutol or levofloxacin for disseminated Mycobacterium avium infections in beige mice., Antimicrobial agents and chemotherapy, vol. 40, no. 4, pp. 1033-5, 1996.
L. E. Bermudez, Wu, M., and Young, L. S., Effect of stress-related hormones on macrophage receptors and response to tumor necrosis factor., Lymphokine research, vol. 9, no. 2, pp. 137-45, 1990.
L. E. Bermudez, Kolonoski, P., Wu, M., Aralar, P. A., Inderlied, C. B., and Young, L. S., Mefloquine is active in vitro and in vivo against Mycobacterium avium complex., Antimicrobial agents and chemotherapy, vol. 43, no. 8, pp. 1870-4, 1999.

Pages